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Based on proteomic analyses we investigated the differences of released molecules in
the conditioned media (CM) from the spinal cord central lesion and adjacent rostral and
caudal segments at 3, 7, and 10 days after spinal cord injury (SCI), in order to specify the
molecular environment within greater extent of tissue damage. Proteins found in CMwere
analyzed by shot-gun MS using nanoLC coupled to an orbitrap. The results showed some
specific proteins at each site of the lesion at 3days. Among the proteins from rostral
and lesion segments, some are related to chemokines, cytokines or to neurogenesis
factors. In contrast, proteins from caudal segments are more related to necrosis factors.
The CM from each spinal segment were used in vitro, on microglial BV2 cell lines and
DRGs explants, showing a lesion site-dependent impact on microglia activation and DRGs
neurite outgrowth. In addition, while naive BV2 cells exhibited insignificant staining for
CX3CR1 receptor, the level of CX3CR1 was strongly enhanced in some BV2 cells after
their stimulation by CM collected from SCI. The molecular data might correlate with
different polarization of activated microglia and macrophages along the rostro-caudal
axis following acute injury. This was partially confirmed in vivo with CX3CR1 receptor,
revealing higher expression in the rostral segment, with potential neuroprotective action.
In addition, the neurotrophic factors released from rostral and lesion segments enhanced
outgrowth of DRGs explants. Taken together these data suggest that regionalization in
terms of inflammatory and neurotrophic responses may occur between rostral and caudal
segments in acute SCI.
Keywords: microglia, proteomic analysis, inflammation, spinal cord injuries, dorsal root ganglion, chemokines,
neurotrophic, secreted protein
INTRODUCTION
Spinal cord injury (SCI) represents one of the most devastating
forms of trauma, often leading to permanent spastic paralysis in
humans (Beattie et al., 2002). After initial primary injury caused
by direct mechanical insult, the spinal cord tissue progressively
undergoes pathological changes that are associated with sec-
ondary damage affecting intact, neighboring tissue (Tator, 1995;
Schwab and Bartholdi, 1996). One of the key events of secondary
processes is related to the development of acute inflammation
characterized by fluid accumulation (edema) and the recruitment
of immune cells (neutrophils, T-cells, macrophages, and mono-
cytes) (Schwab and Bartholdi, 1996; Schwartz et al., 1999). In fact,
spinal cord microglial cells normally function as a kind of reactive
immune cells that begin to respond to signals after pathological
stimuli (injury, infection, or tumors) (Ransohoff et al., 2007) and
are activated at the lesion epicenter (Kreutzberg, 1996).
Although, it has been suggested that microglia/macrophages
can be polarized into M1-neurotoxic or M2-neuroprotective
states, and produce a variety of cytokines, chemokines and neu-
rotrophic factors, the mechanisms regulating microglial polarity
remain unclear (Aguzzi et al., 2013). In this context recent studies
indicate that macrophages can alter their phenotypes and func-
tions according to changes in the spinal cord microenvironment
during sub-acute and chronic phase. Thus, SCI triggers excessive
inflammatory response mediated by the invasion of predomi-
nantly M2 macrophages into and around the central lesion at
sub-acute phase, but not at chronic phase that is involved in
the formation of glial scar (Nishimura et al., 2013). These find-
ings correlate with accumulated data pointing to a chronological
time line expression of different degeneration and regeneration
associated genes that are involved in the pathogenesis and endoge-
nous repair or plasticity during days to months following SCI
(Gerin et al., 2011). However, not only microglia/macrophages
but also astrocytes, meningeal cells and fibroblasts together with
the increased production of inhibitory chondroitin sulfate pro-
teoglycans (CSPGs) are involved in the spinal cord pathogenesis
(Fitch and Silver, 1997).
Moreover, it seems that complex changes in gene and protein
expression as well as in cellular interactions are taking place not
only at the central lesion, but also in adjacent segments (above
and below central lesion). However, the exact mechanisms of
the proteins involved during secondary damage, inflammation,
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recruitment, and polarization of microglia, activation of astro-
cytes and glial scaring, remyelination, or axonal growth and
plasticity, remain to be further explored. Thus, to better under-
stand the secondary damage processes and plasticity, we used a
reliable and reproducible balloon-compression technique to pro-
duce SCI (Vanicky et al., 2001). Sham operated vs. SCI rat spinal
cord tissues were analyzed at 3 days post-lesion; when the polar-
ization of microglia into M2 phenotype seems to transiently (3–7
days) dominate (Kigerl et al., 2009). The collection of tissues from
epicenter and both adjacent segments above (rostral) and below
(caudal) the lesion allowed to study released molecules.
We, have taken advantages of proteomic technology to screen
and identify peptides in each spinal cord segment-derived con-
ditioned medium (CM), obtained in vitro, to better understand
protein composition changes along the rostro-caudal axis after
SCI with time (3, 7, 10 days). Afterwards, we have used these
CM for in vitro tests investigating the BV2 cells activation by
chemotaxis assay, western blot, and M1/M2 polarization through
CX3CR1 and CD206 expression, based on immunocytochemistry
in vitro and in vivo. Chemotaxis assays showed that BV2 cells
were highly responsive to the CM derived from rostral and lesion
segments, compared to CM from caudal site. Efficacy of neu-
rotrophic factors released from rostral and lesion segments was
confirmed on enhanced outgrowth of DRGs explants.
In summary we demonstrate that at 3 days after SCI, a clear
regionalization occurs between the rostral and caudal axes, with
expression of neurotrophic and immune modulatory factors in
the rostral region, in contrast to inflammatory and apoptotic
molecules in the caudal region.
EXPERIMENTAL PROCEDURES
CHEMICALS
All chemicals were of the highest purity obtainable. Water,
formic acid (FA), trifluoroacetic acid (TFA), acetonitrile (ACN),
and methanol (MeOH) were purchased from Biosolve B.V.
(Valkenswaard, the Netherlands). Sequencing grade, modified
porcine trypsin was purchased from Promega (Charbonnieres,
France).
ANIMALS
The study was performed with approval and in accordance to the
guidelines of the Institutional Animal Care and Use Committee
of the Slovak Academy of Sciences and with the European
Communities Council Directive (2010/63/EU) regarding the use
of animals in Research, Slovak Law for Animal Protection No.
377/2012 and 436/2012.
SPINAL CORD TRAUMA
The SCI was induced using the modified balloon compression
technique in adult male Wistar rats (n = 16), according to our
previous study (Vanicky et al., 2001). Manual bladder expres-
sion was required for 3–10 days after the injury. In the sham
group (control, n = 16) a 2-French Fogarty catheter was inserted
at the same level of spinal cord, but the balloon was not inflated
and no lesion was made. SCI animals (n = 16) were divided in
groups processed for immunohistochemistry (n = 4) and for CM
production (n = 12) with corresponding sham-controls.
TISSUE PROCESSING AND IMMUNOHISTOCHEMISTRY
Rats following SCI (n = 4) and sham surgery (n = 4) at day 3
were deeply anesthetized and perfused transcardially with saline,
followed by 4% paraformaldehyde (PFA) in 0.1M phosphate-
buffered saline. Spinal cords were removed, post-fixed in 4% PFA,
embedded in gelatin–egg albumin protein matrix (10% oval-
bumin, 0.75% gelatin, glutaraldehyde) and soaked overnight in
30% sucrose. Each spinal cord was dissected into 1.0 cm blocks
(lesion site, rostral, and caudal segments to the lesion) and 30-
μm thick transverse cryostat (Leica Instruments, Heidelberg,
Germany) sections were cut serially (100μm interval) (n =
60 each segment) and standard immunohistochemistry (IHC)
technique was performed. Tissue sections were incubated in
the following primary antibodies: anti-Iba1 (a marker for
microglia/macrophages, rabbit IgG, 1:1000; Wako Pure Chemical
Industries, Osaka, Japan), anti-ED1 (a marker for monocytes,
mouse IgG,1:500; Chemicon, Millipore, Billerica, MA, USA),
anti-CX3CR1 receptor and anti-CD206 (a marker for M2 phe-
notype, rabbit IgG,1:100; Santa Cruz Biotechnology, Santa Cruz,
CA, USA) that after wash in PBS was followed by secondary
fluorescent antibodies: goat anti-rabbit IgG conjugated with
Texas Red (Alexa Flour 594), goat anti-mouse IgG or goat anti-
rabbit IgG conjugated with Oregon Green dye (Alexa Flour 488).
Fluorescence conjugated secondary antibodies were purchased
from Molecular Probes, Oregon, USA. Omission of the primary
antibody served as the negative control. For nuclear staining,
we used 4-6-diaminidino-2-phenylindol (DAPI) (1:200). Finally,
sections were washed in 0.1M PBS, mounted, and cover slipped
with Vectashield mounting medium (Vector Laboratories, Inc.)
and observed under a fluorescence microscope (Nikon Eclipse Ti,
Japan) and confocal laser scanning microscope (Leica TCS SP5
AOBS, Leica Microsystems, Mannheim, Germany).
IHC QUANTIFICATION
Quantificative analyses of immunofluorescence staining for Iba1,
CX3CR1, and CD206 were performed on 8 sections/per ani-
mal (rostrally/caudally, n = 4 each; captured fluorescence digital
images) at 40× magnification and were analyzed by Image J soft-
ware according to the previous protocol (Jones et al., 2002). For
each SCI and sham group we analyzed totally 32 transverse sec-
tions (Iba1+/CX3CR1+/CD206+ n = 4). In the monochrome
8-bit images we have determined the mean gray level number
of black and white pixels within five identical sampling fields
(250 × 250μm) in following regions: gray matter (summary dor-
sal + ventral areas), white matter divided into Dorsal, Lateral
and Ventral White Matter, and digitally subtracting a background
image of a control section from each image. The threshold values
were maintained at a constant level for all analyses.
COLLECTION OF CM FROM CONTROL AND LESIONED SPINAL CORD
SEGMENTS
Experimental SCI rats (n = 4) at 3, 7, and 10 days and sham-
operated-control rats (n = 4) were sacrificed by isoflurane anes-
thesia followed by decapitation. The spinal cord was pressure
expressed by injecting sterile saline (10ml) throughout the ver-
tebrate canal, along the caudo-rostral axis. Each spinal cord was
macroscopically observed and the central lesion distinguished at
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the Th8-Th9 level. Samples (approximately 1.0 cm each) taken
from the central lesion (Th7-Th11) rostral (Th2-Th6) and cau-
dal (Th12-L3) segments to the site of injury were additionally
chopped into 0.3 cm thick sections/3 per segment and deposited
into a 12-well culture plate containing 1ml DMEM without fetal
calf serum (FCS). After 24 h incubation in a humidified atmo-
sphere with 5% CO2 at 37◦C, 1ml of SCI-derived conditioned
media CM (CM-SCI) were collected (rostral, lesion, caudal seg-
ments) and centrifuged 30min at 15,000 rpm at 4◦C. The same
procedure was performed for obtaining CM from sham spinal
cord tissue. From the 1ml stock 50μL samples were then taken
and subjected to trypsin digestion (24 h, 37◦C) followed by desalt-
ing using C18 ziptips (Millipore). The solution was dried under
vacuum and resuspended in water /5% acetonitrile /0.1% formic
acid before injecting into nanoLC. Unused samples were stored
at −80◦C.
CHEMOTAXIS ASSAYS
The effects of CM obtained from control (CM CTR) or injured
spinal cord (CM SCI) along the rostral (CM RSCI), lesion
(CM LSCI) or caudal segments (CM CSCI) on microglial
recruitment were determined using the Boyden chambers (Cell
Biolabs, CytoSelect™ 96-Well Cell Migration Assay, 5μm) (Smith
et al., 2008). The BV2 cells (Species: mouse, C57BL/6; Tissue:
brain, microglial cells) were purchased from the IRCCS Azienda
Ospedaliera, Universita San Martino (Italy) (Bocchini et al.,
1992) and initially cultured in Roswell Park Memorial Institute
(RPMI) 1640 medium supplemented with 10% FCS and 1%
penicillin/streptomycin (P/S), and split twice a week to obtain
a sufficient number of BV2 cells. Before experiment, cells were
plated in Dulbecco’s Modified Eagle’s Medium (DMEM) with
P/S (all reagents from Invitrogen). Replacement of RPMI with
DMEM did not decrease the viability of BV2 cells nor changed
their morphological pattern (data not shown). In the first experi-
ment, BV2 cells at a concentration of 50,000 per insert were placed
into the upper chamber while the CM from control and from dif-
ferent segments (rostral, lesion and caudal) of the injured spinal
cord were filled into the lower one (1:3, CM: DMEM) and then
cultured for 3 h. Prior to application, the CM from each spinal
segment was centrifuged 10min at 1500 rpm and sterilized with
0.22μmfilters. The protein concentration (2.15–2.8μg/10μl/per
each CM) was assessed by Bradford protein assay. ATP (10μM)
was used as positive control for microglial cell recruitment. The
migrating BV2 cells were detected by Hoechst staining and the
number of cells was counted on dissected membranes trans-
ferred on glass slides and mounted with Vectashield mounting
medium (Vector Laboratories, Inc. on LinkedIn). Three different
counts were performed under a Nikon Eclipse Ti microscope with
motorized stage.
IMMUNOFLUORESCENCE ANALYSIS OF BV2 CELLS
For detection of CX3CR1 receptor, BV2 cells were grown on Poly-
L-Ornithine-Coated Glass Coverslips in DMEM with 10% FBS,
1% P/S, for 24 h and then washed and treated with CM LSCI
(1:3, CM LSCI:DMEM lacking FCS) or CM CTR, for 24 h BV2
cells were fixed with 4.0% paraformaldehyde, treated with 0.2%
Triton X-100, and blocked with 2% normal goat serum (NGS,
Sigma-Aldrich). Afterwards, they were sequentially incubated
with anti-CX3CR1 antibody (1:100, Santa Cruz, USA), followed
by FITC-conjugated goat anti-rabbit IgG, and 4,6-diamidino-
2 phenylindole (DAPI, Sigma-Aldrich, Germany) solution, and
examined using a fluorescence and confocal microscope (Leica,
Germany).
WESTERN BLOT ANALYSES
Western Blot analysis was carried out from BV2 cell extracts as
previously described (Salzet et al., 1993). Blots were blocked with
5% milk in PBS for 45min and incubated overnight at 4◦C with
a rabbit CX3CR1 antibody diluted 1/200. Detection was per-
formed by enhanced chimioluminescence (Amersham, France)
after 1h incubation with a peroxidase-conjugated secondary anti-
body (Aventis, Sanofi Pasteur, France) diluted at 1/20,000.
DORSAL ROOT GANGLION EXPLANTS
DRGs were isolated from the thoracic and lumbar spinal levels
of a total of 3 Wistar rats (P2, n = 50). Under aseptic condi-
tions, the DRG explants were prepared by trimming nerve roots
using microsurgical scissors. Afterwards each explant was trans-
ferred to laminin pre-coated glass slides (0.1mg/ml) in 12-well
tissue culture plates (Costar, Corning, USA) with DMEM/F12
culture medium supplemented with: (i) CM CTR, (ii) CM RSCI
segment, (iii) CM LSCI, (iv) CM CSCI (1:3, CM: DMEM) dur-
ing 7days in vitro (7DIV). Control DRGs neurite outgrowth was
induced with DMEM-F12 containing epidermal growth factor
(EGF) and basic fibroblast growth factor (bFGF) (20 ng/ml/ each
factor, 1% B27, 0.5%N2) during 7DIV. For all DRGs we have used
standard IHC procedures to visualize neurite outgrowth. Briefly,
DRGs were incubated in mouse anti-Neuron-specific class III
beta-tubulin (TUJ1) (1:200; Merck) for 24 h at 4◦C. Afterwards,
they were washed in 0.1M PBS and incubated for 2 h with goat
anti-mouse IgG (Alexa Flour 488). For nuclear staining, we used
DAPI (1:200). Finally, they were mounted, and cover slipped
with Vectashield mounting medium (Vector Laboratories, Inc.).
Digitized images of DRGs/per treatment (n = 6) were captured
and saved with NIS-Elements Ar Microscope Imaging Software
(Nikon). The outgrowth of neurite was analyzed at identical
sampling fields, for each CM experiment by Image J software
according to the above mentioned method applied for primary
antibodies quantification.
STATISTICAL ANALYSIS
All data are reported as the mean ± s.e.m. One-Way ANOVA fol-
lowed by the Tukey-Kramer test for multiple comparisons was
used in the analyses of the Iba1+/CX3CR1+/CD206 in the spinal
sections and for the chemotaxic results. Repeated-measures Two-
Way ANOVA followed by the Tukey-Kramer test was used for the
DRGs/TUJ1+ neurite outgrowth analysis. Statistical significance
was set at ∗p < 0.05; ∗∗P < 0.01, ∗∗∗P < 0.001.
PROTEOMIC STUDIES
Digestion of CM
Fifty μL of the solution of CM obtained from the control spinal
cord and along the lesion or rostral and caudal segments after SCI
were added to 20μL of a solution of DTT (50mM) in NH4HCO3
buffer (50mM) (pH = 8) and heated for 15min at 95◦C. After
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cooling, 20μL of a solution of IAA (100mM) in NH4HCO3
buffer (50mM) were added and the mixture was incubated for
15min at room temperature in the dark. 10μL of a solution of
trypsin (20μg/mL) in NH4HCO3 (50mM) were then added and
the sample was incubated overnight at 37◦C.
Tissue protein extraction
Twentyμm spinal cord tissue sections were mounted on a
parafilm covered glass slide and the tissue was microdissected
manually using a binocular. The pieces were extracted by incubat-
ing in 20μL of 50mM bicarbonate buffer containing 50mMDTT
and 1% SDS at 55◦C for 15min. The extracts were then loaded
on 12% polyacrylamide gel and separated at 70V for 15min and
then 120V until the dye front reaches the other end of the gel.
After migration, the gel was incubated in the gel fixative solu-
tion for 30min and stained with colloidal Comassie brilliant blue
overnight. The stain was removed by washing the gel four times
with distilled deionized water.
In gel digestion
The gel was cut into ten pieces. Pieces were washed with 300μL
of distilled deionized water for 15min, 300μL of ACN for 15min
and 300μL of NH4HCO3100mM (pH8) for 15min. Then a mix
of 300μL of NH4HCO3/ACN (1:1, v/v) for 15min and 300μL
of ACN for 5min. Band pieces were dryed in a Speedvac for
5min. The reduction of cystine residues was made with 50μL of
10mM of DTT in NH4HCO3 100mM (pH8). Pieces were incu-
bated at 56◦C for 1 h. Alkylation of cystine was made with 50μL
of 50mM of IAA in NH4HCO3 100mM (pH8). Pieces were incu-
bated at room temperature in the dark for 30min. Band pieces
were washed a second time with 300μL of NH4HCO3 100mM
(pH8) for 15min. Then a mix of 300μL of NH4HCO3/ACN (1:1,
v/v) for 15min and 300μL of ACN for 5min. Band pieces were
dryed in a Speedvac for 5min. A digestion of band pieces was
made with trypsin (12.5μg/mL) in NH4HCO3 20mM (pH8),
enough to cover pieces. Pieces were incubated at 37◦C overnight.
Peptides were extracted on shaking platform with 50μL of FA
1% two times for 20min, then 150μL of ACN for 10min. The
supernatant was transferred in new tube and dried with Speedvac.
NanoLC-HR-MS/MS
Samples were separated by online reversed-phase chromatog-
raphy using a Thermo Scientific Proxeon Easy-nLC system
equipped with a Proxeon trap column (100μm ID × 2 cm,
Thermo Scientific) and a C18 packed-tip column (100μm ID ×
15 cm, Nikkyo Technos Co. Ltd.). Peptides were separated using
an increasing amount of acetonitrile (5–40% over 110min) at a
flow rate of 300 nL/min. The LC eluent was electrosprayed directly
from the analytical column and a voltage of 1.7 kV was applied
via the liquid junction of the nanospray source. The chromatog-
raphy system was coupled to a Thermo Scientific Orbitrap Elite
mass spectrometer programmed to acquire in a data-dependent
mode. The survey scans were acquired in the Orbitrap mass ana-
lyzer operated at 120,000 (FWHM) resolving power. Amass range
of 400–2000m/z and a target of 1E6 ions were used for the sur-
vey scans. Precursors observed with an intensity over 500 counts
were selected “on the fly” for ion trap collision-induced dissocia-
tion (CID) fragmentation with an isolation window of 2 amu and
a normalized collision energy of 35%. A target of 5000 ions and a
maximum injection time of 200ms were used for CID MS2 spec-
tra. The method was set to analyze the 20 most intense ions from
the survey scan and dynamic exclusion was enabled for 20 s.
Data analyses
Tandem mass spectra were processed with Thermo Scientific
Proteome Discoverer software version 1.3. Resultant spectra were
searched against the Swiss-Prot® Rattus norvergicus database (ver-
sion January 2012) using the SEQUEST® algorithm. The search
was performed choosing trypsin as the enzyme with two missed
cleavages allowed. Precursor mass tolerance was 10 ppm, and
fragment mass tolerance was 0.5Da. N-terminal acetylation,
methionine oxidation and arginine deamination were set as vari-
able modifications. Peptide validation was performed with the
Percolator algorithm. Peptides were filtered based on a q-Value
below 0.01, which corresponds to a false discovery rate (FDR)
of 1%.
Label free quantification with Scaffold 4 software
Scaffold (version Scaffold 4.0.6.1, Proteome Software Inc.,
Portland, OR) was used to validate MS/MS based peptide and
protein identifications and label free quantification (Gstaiger
and Aebersold, 2009). Peptide identifications were accepted if
they could be established at greater than 50% probability by
the Peptide Prophet algorithm (Keller et al., 2002) with Scaffold
delta-mass correction. Protein identifications were accepted if
they could be established at greater than 90% probability and
contained at least 2 identified peptides. Protein probabilities
were assigned by the Protein Prophet algorithm (Choi et al.,
2008). Proteins that contained similar peptides and could not
be differentiated based on MS/MS analysis alone were grouped
to satisfy the principles of parsimony. Normalization was done
on top 3 total ion current (TIC) in addition to spectral
counting.
RESULTS
Here, we investigated nature of the factors released in CM derived
from three spinal cord segments (rostral, central lesion, cau-
dal) obtained 3, 7, and 10 days after SCI and correlated its
molecular composition with the in vitro and in vivo analyses
(Figure 1).
BV2 CELLS ARE STIMULATED WITH CM FROM INJURED SPINAL
TISSUE
Microglia recruitment response to CM from SCI
Proteins secreted from segmental fragments of injured and con-
trol spinal cords were analyzed after 24 h in vitro incubation. The
regionalization between rostral and caudal segments from the
lesion has been taken into account and each collected CM has
been individually tested on microglial BV2 cells using Boyden
chambers. BV2 cells were counted by using Hoechst-labeling
(Figure 2A). More than a 37-fold increase of attached microglial
cells were observed with the CM from the rostral and lesion
regions (Figures 2A,C,D), compared to the CM from control
or ATP application (number of nuclei in the identical sampling
fields: control = 4.2 ± 1.6, rostral = 129.6 ± 8.5, lesion = 145 ±
12, caudal = 27.1 ± 3.8, ATP = 15.0 ± 5.3) (Figures 2A,B).
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FIGURE 1 | Schematic design of the experimental procedure used in this study.
FIGURE 2 | CM SCI-induced BV2 cell chemotaxis in the transwell assay.
Activated BV2 cells were quantified by counting the number of Hoechst-labeled
cells attached to the Boyden membrane after incubation with CM from control
spinal segment (A,B,B’), with CM from rostral (A,C), lesion (A,D) and caudal
(A,E) segments after SCI and ATP (A). Significant increase of attachedmicroglia
occurred when BV2 cells were incubated with CM from rostral (A,C), lesion
(A,D) and caudal (A,E) segments. Note, marked nuclear hypertrophy of
microglia followingCMLSCI activation (C’)when compared to control (B’). Data
are represented as mean ± s.e.m. ∗∗P < 0.01, ∗∗∗P < 0.001, One-Way ANOVA
followed by Tukey-Kramer test. Scale bars (B–E) = 50μm; (B’,C’) = 10μm
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FIGURE 3 | Quantification of DRG explant neurite outgrowth in
response to culture media. M+GF (DMEM+ growth factors), M-GF
(DMEM without growth factors), and conditioned media: CM CTR (control
spinal cord), after SCI: CM RSCI (rostral segment), CM LSCI (lesioned
segment), CM CSC (caudal segment) (A). The image of TUJ1 stained
DRG explants after selecting the area to be analyzed and thresholding
the number of pixels covered by the extending neuritis, but not the DRG
cell body (asterisk) (B). Representative immunofluorescence images of
TUJ1 positive DRG explants exposed to CM RSCI (C), CM LSCI (D), and
CM CSC (E). Scale bars (B–E) = 400μm.
In addition, comparison of microglia recruitment showed 5-fold
higher activity using lesion and rostral CM when compared to
the caudal one (Figures 2A,E). Furthermore, a marked nuclear
hypertrophy of microglia was detected following activation, com-
pared to control (Figures 2B′,C′).
DRGs NEURITE OUTGROWTH
For quantification of neurite growth, the surface area out-
side the ganglion that was covered with neurites was deter-
mined (Figure 3B). This showed that enhanced TUJ1 positive
neurite outgrowth from DRG explants was induced with CM
LSCI (Figure 3D), and about half the growth was observed
after culturing with CM RSCI (Figure 3C), if compared with
control (Figure 3A). Conversely, almost no outgrowth from
DRG explants was found after incubation with CM CSCI
(Figure 3E), CM CTR nor with media lacking GFs (M-GFs)
(Figure 3A). Thus, the outgrowth induced with CM LSCI was
the most pronounced, and DRG explants sent large radial
projections to the peripheral area (<500μm). In addition,
bright field images of DRGs confirmed a high number of
migrating cells with neuron-like bipolar and fibroblast-like
morphology scattered around those explants expressing high
neurite outgrowth (CM CTR, CM LSCI) (Suppl. data 1).
The mean value % of neurite outgrowth for each group
was: 100% ± 9.1 =M + GFs; 4.07% ± 1.28 =M − GFs;
5.42% ± 1.7 = CM CTR; 50.38% ± 3.15 = CM RSCI;
103.9% ± 7.76 = CM LSCI; 4.03% ± 0.76 = CM CSCI. (∗∗∗P <
0.001).
Proteomic studies
We pointed out in our above results that a regionalization
occurred between the rostral and the caudal segments in terms
of factors secreted, i.e., neurotrophic and chemoattractant from
the rostral segment, whereas none were from the caudal one. In
this context, we investigated at a proteomic level the content of
the SCI CM released from each spinal cord segment in order to
identify these secreted factors. These experiments have been done
on 4 SCI rats and 4 sham-operated rats per each survival (3, 7, 10
days). Among the identified proteins, those with a score under 5
were removed from subsequent analyses because they were iden-
tified from the MS/MS to have less than two peptides. We then
evaluated the number of common peptides between the CM of
interest. Each accession number, protein description, gene name
and relative score associated with the selected proteins is reported
in (Suppl. data 2–4). The Venn diagram presented in Figure 4A
illustrates the common identifications between rostral, caudal,
lesion SCI and control without lesion. Specific proteins have also
been detected for each segment after SCI. In fact, 553 specific pro-
teins have been detected in lesion (Figure 4A). 153 ± 3 (n = 5)
proteins are in common between control, rostral and caudal SCI.
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FIGURE 4 | (A) Venn diagram representations of the common
identifications after shot-gun analyses between CM derived from rostral,
caudal, lesion SCI segments and control spinal cord segments without
lesion. (a) consists of a comparison between control (CTL) and lesion (L),
(b) Control (CTL), Rostral (R) and Caudal (C), (c) lesion, rostral, caudal
and (d) control, lesion, rostral or control, lesion, caudal (see Suppl. data
1–4). (B) Label–free quantification of immune modulators, neurotrophic,
and growth factors and apoptotic molecules identified in control, rostral,
caudal, lesion segments using Scaffold_4.0.6.1. (CLCF1, cardiotrophin-like
cytokine factor 1; EMAPII, endothelial monocyte-activating polypeptide;
GDNF, glial cell-derived neurotrophic factor; CDNF, conserved dopamine
neurotrophic factor; MANF, mesencephalic astrocyte-derived neurotrophic
factor; HDGF, mesencephalic astrocyte-derived neurotrophic factor;
MFG-E8, milk fat globule-EGF factor 8 protein; FGF, fibroblast growth
factor; MSP, macrophage stimulating protein; PDGF, platelet-derived
growth factor; FIGF, C-Fos induced growth factor).
In addition, 14 ± 1 (n = 5) proteins are in common between
control and rostral SCI whereas only 9 ± 4 (n = 5) are found
in both caudal SCI and control (Figure 4Aa–d). Comparison
between caudal and rostral SCI showed 481± 3 (n = 5) pro-
teins in common. Experiments have been redone 5 times and the
number of proteins identified in each condition was very close
(±4). The Venn diagram (between rostral and caudal SCI after
elimination of the proteins in common with the ones detected
in normal SC) confirmed the chemotaxis data. In fact, not only
do the rostral and caudal CM have proteins in common but
also some specific proteins compared to each other (Figure 4A).
As presented in Table 1, for the first time in shot-gun analyses
from CM, chemokines have been identified and quantified by
label–free quantification (Suppl. data 5) in the lesion and rostral
segments, e.g., CXCL1; CXCL2; CXCL7, CCL2, CCL3, CCL22,
CLCF1, EMAP II. These chemokines and the neurotrophic factors
(TGF®, FGF-1, PDGF, and FIGF1) detected in these regions
clearly showed the presence of factors that are known to be
immune-modulators and are neurotrophic (Figure 4B). Together,
these factors are known to polarize the macrophages/microglial
cells in the M2 phenotype (Figure 4B). Thus, three days after SCI,
factors secreted by the cells present at the lesion and in the ros-
tral segment (Table 1) are in neuroprotective and neurotrophic
environment whereas those from the caudal region are more
apoptotic. The complete screening of the CM confirmed such
evidence. In fact, more neurotrophic factors have been detected
in the lesion and rostral part, i.e., CTGF (Connective tissue
growth factor), NOV (Protein NOV homolog), PIGF (Placenta
growth factor), FGF-1 (Fibroblast growth factor 1), BMP 2 or
BMP3 (Bone morphogenetic proteins (2 or 3), NGF, PGF, TGF
beta (1–3) (Transforming growth factor beta), periostin, GAP-43,
neurotrimin, neurofascin, Hepatocyte growth factor-regulated
tyrosine kinase substrate (HGS). Also, molecules involved in
neuronal development/differentiation/neuronal migration, i.e.,
CRIP1 (Cysteine-rich protein 1), DRP-5 (Dihydropyrimidinase-
related protein 5), Negr1 (Neuronal growth regulator 1), NCAN
(Neurocan core protein), CD44, Wnt8, syndecan-4, nexin, Bcl-
2, were identified. Specific factors involved in immune cell
chemotaxis or cellular adhesion, including complement factors
(C1qb, C1qc, factor D, factor I, CD59), tetraspanins (CD9,
CD82), and CD14 have also been characterized. In the contrast,
proteins from the caudal region are more related to necrosis fac-
tors (BAX, BAD, Casapase 6, neogenin), cytoskeleton proteins,
synaptic vesicle exocytosis, chemoatractant factors and neuronal
postsynaptic density (Figure 4B, Table 1). Only BMP2, BMP3,
and HGS have been detected. Comparison of proteins identified
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Table 1 | List of proteins identified by shot-gun issue from CM (24h)
of central lesion, adjacent rostral and caudal segments after SCI at 3
days.
Protein family Accession
number
Protein name SCI 3D
Lesion Rostra Cauda
Chemokines P14095 CXCL1
P30348 CXCL2
Q99ME0 CXCL7
O08565 CXCR4
P14844 CCL2
P50229 CCL3
Q5I0L5 CCL22
Cytokines Q320X2 EMPAII
F7EKG3 CLCF1
Lectins O88201 CLEC11a
P11762 GAL-1
P08699 GAL-3
CD P40241 CD9
Q63691 CD14
P26051-2 CD44 isoform 1
P27274 CD59
Q6P9V1 CD81
O70352 CD82
D3ZNV9 CD93
P20786 CD140a
Complement P31720 C1qa
P31721 C1qb
P31722 C1qc
P01026 C3
P08649 C4
P32038 Factor D
Q9WUW3 Factor I
Growth factors P07936 GAP-43
Q9R1E9 CTGF
Q9QZQ5 NOV
Q63434 PLGF
P70521 MSP
P70490 MFG-E8
Q63740 PDGF
O35251 FIGF
D3ZNW5 Neurofascin
P17246 TGFb1
Q07257-2 TGFb2
Q07258 TGFb3
P61149 FGF-1
P49002 BMP2
P49001 BMP3
D3ZCR6 Periostin
Q9JJ50-2 HGS
Q62718 Neurotrimin
(Continued)
Table 1 | Continued
Protein family Accession
number
Protein name SCI 3D
Lesion Rostra Cauda
Response to
stress
P04094 proenkephalin
Q8N729 Neuropeptide
W Precursor
Neuronal
development/
differentiation
P47875 Cysteine-rich
protein 1
P36201 Cysteine-rich
protein 2
Q9JHU0 DRP-5
Q9Z0J8 Negr1
P55067 Ncan
The black shade corresponds to the proteins identified in the concerned case.
from the lesion rostral and caudal regions gave 122 proteins spe-
cific to the lesion site, 100 to the rostral segment, and 146 to the
caudal one (Table 1). Nevertheless, 60 proteins are in common
between the rostral and the lesion, and among these proteins,
chemokines and neurotrophic factors have been only detected in
these segments and never in the caudal part. Thus, 3 days after
SCI, a clear regionalization occurs between the rostral and caudal
regions (Table 1). These data can explain why initial sprouting
and neurite outgrowth occur within the rostral and lesion parts
and no regenerative processes can be found in the caudal part,
although microglial cells are present and are in an activated state.
Tissue proteomic analyses have been performed 3, 7, and 10 days
after SCI. 801 common proteins to both 3 conditions have been
identified. 58 specific proteins have been identified at 3 days, 446
at 7 days, 62 at 10 days after SCI. 230 proteins are common to
both 7 and 10 days after SCI whereas only 41 between 3 and
10 days after SCI. Neurotrophic factors have been identified at
3 days, diminished at 7 days and disappeared at 10 days after
SCI. However 10 days after SCI, proteins related to synaptogenesis
have been detected, e.g., R–SNARE synaptobrevine, Q–SNAREs
(SNAP25), GTPases (Rab proteins family), les synaptogenines,
syntaxines, synaptotagmine. This reflected that 10 days after SCI
proteins involved in axonal reconnection and synaptic transmis-
sion are expressed. This reflects that a neurorepair process has
started (Table 2). In contrast, at the caudal segment, the protein
profile is always inflammatory and apoptotic whatever the days
after SCI (Data not shown).
MICROGLIA EXPRESSION IN CONTROL AND INJURED SPINAL CORD
TISSUE
Antibodies against Iba1 exhibitedmoderate expression of resident
microglia (Figures 5A,A′,A′′). After SCI, microglia changed into
an activated phenotype: marked cellular hypertrophy and thick,
short and radially projecting processes with fewer ramifications
(Figures 5B,B′,B′′,C,C′). This was confirmed by quantification
analyses, which showed some disparities between microglia
accumulated in the dorsal white matter of the rostral and cau-
dal spinal cord segments (Figures 5C,C′, 6A–D). Significant
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Table 2 | Identified proteins from rostral tissue sections in time
course after SCI.
Protein family Accession
number
Protein name 3 Days 7 Days 10 Days
Neurotrophic
factors
P07936 GAP-43
Q9R1E9 Cntf
Q9QZQ5 NOV
Q63434 Plgf
D3ZNW5 Neurofascin
Q923W4 HDGR3
P0C5H9 MANF
P17246 TGFb1
Q07257-2 TGFb2
Q07258 TGFb3
P61149 Fgf-1
P49002 BMP2
P49001 BMP3
D3ZCR6 Periostin
Q9JJ50-2 HGS
Q62718 Neurotrimin
Q6P686 Ostf1
Synaptogenesis
factors
P60881 SNAP25
SNAP29
D4ABK1 SYNGR
Q03410 SYCP1
Q62910-5 SYNJ-1
P09951-2 SYN1
Q63537 SYN2
P21707 SYT1
P29101 SYT2
Q02563 SYV2A
P07825 SYNPH
Q5EGY4 Synpatobrevin
P63012 Rab3a
A1L1J8 Rab5b
P09527 Rab7A
P35281 Rab10
O35509 Rab11
Q6AXT5 Rab23
Q99P74 Rab27
Q6GQP4 Rab31
The gray shade corresponds to the proteins identified in the concerned case.
enhancement of Iba1 positive microglia occurred in the rostral
dorsal white matter (Figure 6B), while in other areas we did not
detect significant differences between the rostral and caudal seg-
ments. The spinal cord tissue at the central lesion was severely
damaged, losing its typical anatomical architecture (Suppl. data
6). Therefore, we could not quantify Iba1 positive profiles at
the lesion site. In addition, the entire dissected central segment
(±5.0mm) showed dense and homogenous infiltration of Iba1
and ED1 positive macrophages (Suppl. data 7). However, out of
the central lesion, toward the rostral or caudal segments, Iba1
macrophages together with migrated ED1 monocytes occupy
mainly the lesion cavity and accumulate at the lesion penum-
bra (Suppl. data 7). In addition, we could clearly distinguish
the monocyte-derived amoeboid Iba1 microglia concentrated
within the dorsal WM, while hypertrophied microglia with ram-
ified processes retained at the gray matter tissue (Suppl. data
7). Furthermore, by immunofluorescent double labeling of ED1
and Iba1 we confirm the distribution of macrophages through-
out the rostro-caudal extent of spinal contusion lesions (Suppl.
data 7). All data are included in Table 3. To confirm the key role
of inflammation and not gliosis at 3 days after SCI we studied
response of astrocytes by GFAP IHC. Here we show that injury
resulted into decreased number of GFAP positive profiles, with
short processes surrounded by debris. These GFAP+ profiles were
impaired, when compared to fine star like astrocyte morphology
found in sham spinal cord sections (Suppl. data 8).
EXPRESSION OF CX3CR1 RECEPTOR AND CD206+ PROFILES ALONG
THE ROSTRO-CAUDAL AXIS IN SPINAL CORD TISSUE
The proteomic data showed that factors released from the rostral
and lesion segments express neuroprotective and immunomod-
ulatory properties, whereas the ones found in the caudal are
more inflammatory. In this context, we focus our attention
on the CX3CR1 receptor which is known to be expressed in
immune cells expressing an M2 profile characterized by pro-
duction of neurotrophic factors and immune modulators like
CXCL1, CXCL2, CXCL3, CCL1, CCL2, CCL22, EMAP II, and
CLCF1, factors that were identified in CM derived from ros-
tral and lesion segments. Expression of CX3CR1 in sham spinal
cord tissue was low, with homogenous distribution in whole
layers of the spinal cord with occasionally labeled microglia
(Figures 7A,A′,C,D). However, SCI after 3 days induced a signif-
icant upregulation of CX3CR1 expression in the dorsal, ventral
gray and white matter. This upregulation seems to co-localize
with spinal microglia and recruited monocytes within dam-
aged tissue (Figures 7B,B′,E). Higher expression of CX3CR1 was
detected in rostral segments (Figures 7B,B′,E) when compared to
the caudal spinal cord tissue at day 3 post-injury which was val-
idated by quantification of CX3CR1 immunohistochemistry in
coronal sections (Figure 8D). Similarly, CD206+ macrophages
significantly increased in both rostral and caudal spinal seg-
ments when compared to corresponding areas of sham operated
rats. However, we did not found differences along the rostro-
caudal axis, thus the white and gray matter were infiltrated
with large multipolar macrophages with elongated processes
(Figures 7C,C′, 8E).
In order to evaluate the part of infiltrating macrophage that
can also express the CX3CR1 receptor, double labeling using anti-
CX3CR1 (red) and anti-ED1 (green) was performed in the dorsal
white matter at the level of rostral and caudal segments three days
after SCI. Results confirm that a clear labeling for CX3CR1 is
found in the rostral segment (Figure 8A) and lower in the caudal
segment (Figure 8B). No co-localization was detected between
CX3CR1 and ED1 labeling indicating that macrophages did not
express CX3CR1 receptors (Figure 8C, arrows indicate the Iba1
labeling distinct from the ED1).
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FIGURE 5 | Comparison of Iba1 immunoreactivity (IR) in coronal
thoracic spinal cord sections of sham rats (A,A’) and rats 3 days
after injury in rostral (B,B’) and caudal segments (C,C’) in the
dorsal (upper) and ventral horn (lower panel). Note, significantly
increased number of activated Iba1-positive microglia in both rostral
and caudal segments within the dorso-ventral axis of gray matter as
well as throughout corresponding white matter. Scale bars
(A,A’–C,C’) = 150μm.
MODULATION OF CX3CR1 IN BV2 CELLS
Naive BV2 cells did not show any signal for CX3CR1
(Figure 9A) similar to the negative control, when using
only the secondary antibody (Figure 9B). Following 24 h
stimulation of BV2 cells with CM RSCI, multipolar or round
cells (arrows) expressed strong CX3CR1 immunofluorescence
(Figures 9C,C′,D). Interestingly, it can be noticed that the
labeling was either vesicular (Figure 9C′), or membranous
(Figure 9D), which demonstrates an receptor from Golgi to
membrane after activation of the BV2 cells with CM from an
injured spinal cord. No labeling using anti-CKR2, a marker for
M1 polarization of macrophages and microglial cells, has been
found in control nor in BV2 cells stimulated with CM R SCI (data
not shown). Western blot analysis showed the presence of a spe-
cific band at 34 kDa (Figure 9E) corresponding to the CX3CR1
receptor only in BV2 cells stimulated with CM RSCI.
DISCUSSION
In the present study, we show that the activated Iba1 positive
microglia increased in all evaluated areas following SCI, but
the significant differences between rostral and caudal segments
occurred only within the dorsal white matter, where the impact of
damage is most prominent in this SCI animal model. Thus, this
discrepancy could be accounted in part to the presence or absence
of macrophages derived from CNS-residing microglia or from
blood-derived monocytes invading the most damaged regions
at the rostral and caudal spinal levels (Mawhinney et al., 2012).
Previous work have shown that after SCI, pro-inflammatory
cytokines are upregulated by microglia and macrophages in the
first few days after injury. These inflammatory mediators are also
produced by other cell types in the lesioned spinal cord (Pineau
and Lacroix, 2007; Pineau et al., 2010). Thus, after SCI, a com-
plex array of chemokines and cytokines regulate myelopoiesis and
intraspinal trafficking of myeloid cells. As these cells accumulate
in the injured spinal cord, the collective actions of diverse cues in
the lesion environment help to create an inflammatory response
marked by tremendous phenotypic and functional heterogeneity.
Indeed, it is difficult to attribute specific reparative or injurious
functions to one or more myeloid cells because of convergence
of cell function and difficulties in using specific molecular mark-
ers to distinguish between subsets of myeloid cell populations
(Hawthorne and Popovich, 2011). The temporal activation of
the myeloid cell lineage leads within minutes of SCI to the cre-
ation of a heterogeneous network of multifunctional cells that
could be able of promoting injury and repair of neural tissue.
Microglia are among the first myeloid cells to be set in motion,
responding to changes in extracellular ions and ATP within min-
utes to hours post-injury followed by neutrophils (Hawthorne
and Popovich, 2011). Neutrophils arrive first between 3 and 24 h
post-injury. Then monocytes arrive later, ∼2 to 3 days post-
injury with maximal infiltration occurring 1–2 weeks post-injury.
At 3 days post-injury data obtained by cDNA microarray and
quantitative real-time PCR analyses, showed that macrophage
expressed M1 and M2 markers, but the M1/M2 ratio determines
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FIGURE 6 | Density of Iba1-IR microglia (n = 4) in the spinal cord
of sham and rats after SCI in gray (A), White Matter (B,C,D);
Dorsal White Matter (B), Lateral White Matter (C) and Ventral
White Matter (D). Density of Iba1-IR positive microglia was
significantly higher in all analyzed areas after SCI when compared to
sham. Significant differences between rostral and caudal segments
occurred only at the dorsal white matter (B). Data are presented as
mean ± s.e.m., ∗P < 0.05 (B–D), ∗∗∗P < 0.001 (A,B) for sham vs.
SCI, or rostral to caudal after SCI for group comparison (ANOVA)
followed by Tukey-Kramer test.
Table 3 | Quantification of Iba1, CX3CR1 and CD206 immunoreactivities in sham, SCI tissue from rostral and caudal segments at 3 days.
Sham rostral SCI rostral Sham caudal SCI caudal
DENSITY OF Iba1
GM 14.6±1.5 9.1±1.3 15.5±0.4 20.3± 1.4
WMD 12.1±1.4 24.6±6.2 12.8±0.9 20.7± 3.7
WML 10.8±1.7 16.1±6.4 11.3±0.8 16.1± 3.9
WMV 8.6±1.4 12.2±1.3 11.2±4.6 15.6± 4.8
DENSITY OF CX3CR1
GM 5.1±1.07 22.8±3.2 4.2±1.8 16.2± 3.8
WM 2.0±1.32 17.27±4.4 3.0±1.6 8.0± 2.6
DENSITY OF CD206
GM 8.8±1.1.7 27.8±4.6 9.2±1.9 28.2± 2.8
WM 4.8±1.2.1 28.4±5.4 5.4±2.4 26.8± 4.4
whether CNS macrophages contribute to axonal regeneration
after SCI (David and Kroner, 2011). Here we also confirm that
CX3CR1 immunoreactivity was up-regulated after SCI, reveal-
ing most prominent expression within the gray and white matter
of rostral spinal segments. This may coincide with both acti-
vated intraspinal microglia as well as with monocytes invading
the lesion already 3 days post-injury, as confirmed in the present
study with ED1 immunoreactivity. It is important to point out
that monocyte recruitment after SCI is a dynamic process that
initiates within the first days post injury, but is further accelerated
during longer survival (Kullberg et al., 2001; Stanislaus et al.,
2001). However, in the present study, co-localization experiments
between CX3CR1 and ED1 did not confirm that macrophage
expressed anM2 profile, while it seemsmore likely to be expressed
in resident microglia.
Based on advanced proteomic analyses, we were trying to find
a correlation between the immune response along the rostro-
caudal axis and the content of released molecules 3, 7, and 10 days
after injury. This is the first time that chemokines were identified
by shot-gun analysis in the CM derived from rostral to caudal
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FIGURE 7 | Comparison of CX3CR1 expression in representative
cross sections of thoracic spinal cord from sham and SCI rats at
the rostral and caudal segmental levels. CX3CR1 showed low
expression pattern in sham, throughout GM (dorso-ventral axis) and
WM (A,A’,D), while injury stimulated CX3CR1 up-regulation (B–E),
particularly at rostral segments (B,B’,E). Note, higher magnification of
homogenous-membranous pattern of CX3CR1 in sham (D), from
A’ = boxed area, or vesicular-dot-like patter of CX3CR1 after injury,
rostral segment (E), from B’ = boxed area. Scale bars (A–C’) =
100μm, (D,E) = 50μm. A representative profile of CD206 (n = 4)
expression in rostral spinal cord sections from sham (C) and SCI rats.
Note, CD206+ macrophage like profiles with ramified and elongated
processes after SCI. In the negative control no CX3CR1 or CD206+
expression occurred (F). Scale bars (A–C’) = 100μm, (D,E) = 50μm.
spinal cord segments. In particular, the immune factors (CCL2,
CCL3, CCL22, CXCL1, CXCL2, CXCL7, EMPAII, CLCF1) that
were detected in the CM from rostral segments with the neu-
rotrophic factors (CTGF, NOV, PIGF, FGF-1 BMP 2, BMP3, NGF,
PGF, TGF beta (1–3) periostin, GAP-43, neurotrimin, HGS) favor
differentiation of microglia cells toward the M2 rather than the
M1 phenotype. These data are in line with our findings show-
ing increased CX3CR1 expression in rostral spinal segments as
well as with previous data of M2 microglia polarization at the
central lesion 3 days after SCI (Kigerl et al., 2009). In contrast
to CX3CR1, the CD206+ profiles revealed similar response at
both rostral and caudal segments. Furthermore, in vitro chemo-
taxis assays confirmed that BV2 cells were highly responsive to the
cytokine cocktail present in the CM from lesion and rostral sites.
Interestingly, the BV2 migratory potency induced by CM derived
from rostral and lesion segments was 37-fold higher compared to
the ATP or LPS stimulations that increase their migration by close
to 3-fold due to the specific factors found in the complex CM
(Rahmat et al., 2013). Our immunocytochemical studies prove
that activated BV2 cells exposed to CM from the rostral segment
over-expressed the CX3CR1 receptor, and this overexpression is
known to correspond with the M2 profile. This was strengthened
by western blot analysis and lack of labeling with C2KR, an M1
receptor. These data together with in vivo CX3CR1 expression
are in close coherence with published transcriptomic experiments
showing that in the injured spinal cord M2 gene expression is
transiently expressed during 7 days after injury, while theM1 gene
expression is maintained for up to 1 month (Kigerl et al., 2009).
Moreover, a direct role of CSPG in controlling microglial and
macrophage behavior after SCI was demonstrated. It seems that
beneficial role of CSPG during the acute stage (regulating their
phagocytosis or neurotrophic factor secretion) and its deleterious
effect at later stages emphasizes the need to retain the endogenous
potential of this molecule for recovery by controlling its levels at
different stages of post-injury repair (Rolls et al., 2008).
Our tissue proteomic data also confirm this point. In fact, a
temporal-spatial analysis in tissue proteomic has been undertaken
at the rostral and caudal segment levels, 3, 7, and 10 days after SCI.
Results shown that the proteome pattern is modified in course of
time in the rostral segment whereas the caudal segment present
the same pattern whatever the time after SCI. Neutrophic factors
are found at 3 and 7 days after lesion and disappeared at 10 days.
They are replaced by synaptogenesis factors reflecting the fact that
a neurorepair process is taking place after 10 days SCI at the level
of the rostral segment. These data are in line with the DRG experi-
ments and our previous in vivo results demonstrating that neurite
outgrowth takes place from rostral to lesion but never from cau-
dal to lesion (Novotna et al., 2011) Furthermore, the content of
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FIGURE 8 | Cross sections through dorsal white mater at the level of
rostral (A) and caudal (B) segments of the injured spinal cord stainedwith
CX3CR1 (red) and ED1 (green) antibodies revealing increased expression
of CX3CR1 (red) in rostral segment compared to caudal (arrows). Note,
no co-localization between CX3CR1 and ED1 labeled macrophages (see
arrows indicated red dot for CX3CR1 labeling) (C, confocal image). Density of
CX3CR1+ (n = 4) and expression of CD206 profiles (n = 4) in the spinal cord
sections of sham and 3 days after SCI in White /Gray Matter (D,E). (D) Density
of CX3CR1was significantly higher when comparing Sham (SH) sections with
sections from injured spinal cord (SCI), sections from rostral (R SCI)
compared with caudal (C SCI) segment within WM/GM. (E) CD206+profiles
significaly increased when compared Sham (SH) sections with sections from
injured spinal cord (SCI), not between R SCI and C SCI sections. Data are
presented as mean ± s.e.m., ∗P < 0.05, ∗∗∗P < 0.001 for sham vs. SCI, or
rostral to caudal after SCI for group comparison W/G matter (ANOVA)
followed by Tukey-Kramer test. Scale bars (A,B) = 50μm, (C) = 20μm.
FIGURE 9 | CX3CR1 expression in control BV2 cells (A), stimulated
with CM LSCI (C). Spindle shaped, multipolar or round BV2 cells
following CM LSCI stimulation expressed intense CX3CR1 IR (C,D).
Scale bars (A–D) = 50μm. Control (B), only secondary antibody. Inset
picture corresponds to Western blot analyses using anti-CX3CR1 from
control or activated BV2 with CM LSCI (E). Note, the band at 34 kDa
correspond to the CX3CR1 and the band at 60 kDa is an unspecific
band.
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chemokines, lectins, and growth factors in the rostral but not in
the caudal segment clearly document the immediate inflamma-
tory response together with activity-dependent factors released by
neurons and glia.
In order to investigate the neurotrophic role of CM derived
from lesioned tissue, we have also undertaken studies of neu-
rite outgrowth in rat DRG explants. Our data validate that
pronounced neurite sprouting of DRGs facilitated by CM from
rostral and lesion segments are most likely mediated by the
content of neurotrophic factors, i.e., FGF-1, NGF, PGF, BMP
2 or BMP3, GAP-43, neurotrimin, neurofascin, and other
molecules involved in neuronal development/differentiation/
migration. Although the principal role of NGF/TrkA pathways
in sensory axon outgrowth have been widely demonstrated,
other neurotrophic factors including the BMPs (members of the
TGFβ superfamily) or GAP-43 have to be taken into account.
Particularly, the Smad1-dependent BMP signaling is develop-
mentally regulated and governs axonal growth in the dorsal
root ganglion neurons. Similarly, GAP-43, a membrane-bound
protein, is expressed in neurons during axonal outgrowth devel-
opment and is significantly up-regulated in DRGs during regen-
eration (Tsai et al., 2007; Parikh et al., 2011).
Taken together, these data could have a clear impact in clin-
ics. It will be more important to stimulate neurite sprouting
at the caudal region by inhibiting inflammation and polariza-
tion of M1 cells to the M2 state. These results demonstrate
that each segment of the lesion has to be taken into con-
sideration independently from each other in order to modu-
late inflammation, stimulate neurite outgrowth and functional
reconnection.
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